作者: Philip T. Cagle , Timothy Craig Allen
DOI: 10.5858/ARPA.2012-0508-RA
关键词:
摘要: Context.—The advent of genotype-based therapy and predictive biomarkers for lung cancer has thrust the pathologist into front lines precision medicine this deadly disease. Objective.—To ...